Role of TGF-beta family in osteoclastogenesis induced by RANKL
- PMID: 11747986
- DOI: 10.1016/s0898-6568(01)00221-2
Role of TGF-beta family in osteoclastogenesis induced by RANKL
Abstract
Recent studies have revealed that both transforming growth factor-beta (TGF-beta) and activin A play pivotal roles in osteoclastogenesis. In this report, we show that the effect of TGF-beta family members, TGF-beta1 and activin A, but not BMP-2, enhance multinucleated osteoclast-like cell (OCL) formation induced by receptor activator of NF-kappaB ligand (RANKL) in isolated bone marrow macrophages and monocytic cell line, RAW264.7. TGF-beta1 and activin A caused the growth suppression and concomitant expression of tartrate-resistant acid phosphatase (TRAP) and c-Src, without inducing syncytium formation or increasing the survival rate in RAW264.7 cells. Although TGF-beta1 and activin A had no effect on NF-kappaB and JNK activities, these factors enhanced the expression of JunB, a component of the AP-1 transcriptional complex. These results suggest that TGF-beta1 and activin A may function as commitment factors in osteoclastic differentiation, not as a crucial component for terminal differentiation to form multinucleated OCLs nor in OCL survival.
Similar articles
-
The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.Calcif Tissue Int. 2002 Nov;71(5):437-46. doi: 10.1007/s00223-001-1138-3. Epub 2002 Sep 4. Calcif Tissue Int. 2002. PMID: 12202955
-
Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.J Cell Biochem. 2003 Sep 1;90(1):59-67. doi: 10.1002/jcb.10613. J Cell Biochem. 2003. PMID: 12938156
-
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.J Lipid Res. 2006 Aug;47(8):1739-48. doi: 10.1194/jlr.M600151-JLR200. Epub 2006 May 15. J Lipid Res. 2006. PMID: 16702601
-
[BMP and osteoclastogenesis].Clin Calcium. 2006 May;16(5):809-15. Clin Calcium. 2006. PMID: 16679623 Review. Japanese.
-
Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.Endocr Rev. 2011 Jun;32(3):387-403. doi: 10.1210/er.2010-0018. Epub 2010 Dec 20. Endocr Rev. 2011. PMID: 21173384 Free PMC article. Review.
Cited by
-
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.Int Orthop. 2014 Mar;38(3):635-47. doi: 10.1007/s00264-013-2201-1. Epub 2013 Dec 19. Int Orthop. 2014. PMID: 24352822 Free PMC article. Review.
-
Identification of the Main Active Components and Mechanism of Wang Bi Tablet in Treating Rheumatoid Arthritis Based on Integrative Pharmacology.Front Pharmacol. 2021 Jun 4;12:669551. doi: 10.3389/fphar.2021.669551. eCollection 2021. Front Pharmacol. 2021. PMID: 34149422 Free PMC article.
-
Autologous blood preparations rich in platelets, fibrin and growth factors.Oral Implantol (Rome). 2016 Jul 23;8(4):96-113. doi: 10.11138/orl/2015.8.4.096. eCollection 2015 Oct-Dec. Oral Implantol (Rome). 2016. PMID: 28042422 Free PMC article. Review.
-
The association of transforming growth factor beta 1 gene polymorphisms with arthritis: a systematic review and meta-analysis.Clin Exp Med. 2021 May;21(2):331-340. doi: 10.1007/s10238-020-00678-5. Epub 2021 Jan 8. Clin Exp Med. 2021. PMID: 33417083
-
CD109 plays a role in osteoclastogenesis.PLoS One. 2013 Apr 12;8(4):e61213. doi: 10.1371/journal.pone.0061213. Print 2013. PLoS One. 2013. PMID: 23593435 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous